Position in GH
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$4,650
+$1,695 QoQ
Shares Held
31
-3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#537
of 593 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $416,657 across 19 Diagnostics & Research names. GH ranks #13 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
161 | $80,718 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
302 | $58,352 | |
| 3 | DHR |
Danaher Corp /De/
|
208 | $39,619 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
69 | $36,324 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
28 | $35,770 | |
| 6 | WAT |
Waters Corp /De/
|
93 | $34,878 | |
| 7 | A |
Agilent Technologies, Inc.
|
260 | $34,535 | |
| 8 | LH |
Labcorp Holdings Inc.
|
69 | $19,320 |
All Filings in GH
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,650 | 31 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $2,955 | 32 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,166 | 31 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $1,936 | 31 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $1,613 | 31 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $852 | 20 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $580 | 19 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $206 | 9 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $375 | 13 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $123 | 6 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $27 | 1 | Shares | Sole | 2024-01-29 | |
| No filing history on record for this holder in this stock. | ||||||